BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mo F, Tang Y, Du P, Shen Z, Yang J, Cai M, Zhang Y, Li H, Shen H. GPR39 protects against corticosterone-induced neuronal injury in hippocampal cells through the CREB-BDNF signaling pathway. J Affect Disord 2020;272:474-84. [PMID: 32553391 DOI: 10.1016/j.jad.2020.03.137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu R, Bai L, Liu M, Wang R, Wu Y, Li Q, Ba Y, Zhang H, Zhou G, Yu F, Huang H. Combined exposure of lead and high-fat diet enhanced cognitive decline via interacting with CREB-BDNF signaling in male rats. Environ Pollut 2022;:119200. [PMID: 35364187 DOI: 10.1016/j.envpol.2022.119200] [Reference Citation Analysis]
2 Doboszewska U, Sawicki J, Sajnóg A, Szopa A, Serefko A, Socała K, Pieróg M, Nieoczym D, Mlyniec K, Nowak G, Barałkiewicz D, Sowa I, Wlaź P. Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy—The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene. Cells 2022;11:1987. [DOI: 10.3390/cells11131987] [Reference Citation Analysis]
3 He Y, Xu L, Li Y, Tang Y, Rao S, Lin R, Liu Z, Chen H. Synergistic integration of dihydro-artemisinin with γ-aminobutyric acid results in a more potential anti-depressant. Bioorg Chem 2021;110:104769. [PMID: 33677247 DOI: 10.1016/j.bioorg.2021.104769] [Reference Citation Analysis]
4 Davis CM, Bah TM, Zhang WH, Nelson JW, Golgotiu K, Nie X, Alkayed FN, Young JM, Woltjer RL, Silbert LC, Grafe MR, Alkayed NJ. GPR39 localization in the aging human brain and correlation of expression and polymorphism with vascular cognitive impairment. Alzheimers Dement (N Y) 2021;7:e12214. [PMID: 34692987 DOI: 10.1002/trc2.12214] [Reference Citation Analysis]
5 Xie S, Jiang X, Doycheva DM, Shi H, Jin P, Gao L, Liu R, Xiao J, Hu X, Tang J, Zhang L, Zhang JH. Activation of GPR39 with TC-G 1008 attenuates neuroinflammation via SIRT1/PGC-1α/Nrf2 pathway post-neonatal hypoxic-ischemic injury in rats. J Neuroinflammation 2021;18:226. [PMID: 34645465 DOI: 10.1186/s12974-021-02289-7] [Reference Citation Analysis]
6 Laitakari A, Liu L, Frimurer TM, Holst B. The Zinc-Sensing Receptor GPR39 in Physiology and as a Pharmacological Target. Int J Mol Sci 2021;22:3872. [PMID: 33918078 DOI: 10.3390/ijms22083872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tang Y, Yang J, Ye C, Xu X, Cai M, Zhang Y, Lu H, Mo F, Li H, Shen H. miR-182 mediated the inhibitory effects of NF-κB on the GPR39/CREB/BDNF pathway in the hippocampus of mice with depressive-like behaviors. Behav Brain Res 2021;418:113647. [PMID: 34743948 DOI: 10.1016/j.bbr.2021.113647] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Siodłak D, Nowak G, Mlyniec K. Interaction between zinc, the GPR39 zinc receptor and the serotonergic system in depression. Brain Res Bull 2021;170:146-54. [PMID: 33549699 DOI: 10.1016/j.brainresbull.2021.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gao L, Zhang Y, Sterling K, Song W. Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential. Transl Neurodegener 2022;11:4. [PMID: 35090576 DOI: 10.1186/s40035-022-00279-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
10 Chen T, Zheng M, Li Y, Liu S, He L. The role of CCR5 in the protective effect of Esculin on lipopolysaccharide-induced depressive symptom in mice. Journal of Affective Disorders 2020;277:755-64. [DOI: 10.1016/j.jad.2020.08.065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Xu Y, Barnes AP, Alkayed NJ. Role of GPR39 in Neurovascular Homeostasis and Disease. Int J Mol Sci 2021;22:8200. [PMID: 34360964 DOI: 10.3390/ijms22158200] [Reference Citation Analysis]
12 Zhang L, Zhang Y, Zhu M, Pei L, Deng F, Chen J, Zhang S, Cong Z, Du W, Xiao X. An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Xiong-Pi-Fang in Treating Coronary Heart Disease with Depression. Front Pharmacol 2021;12:590602. [PMID: 33867976 DOI: 10.3389/fphar.2021.590602] [Reference Citation Analysis]